{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/AARD/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:27:36.340Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11158,"canonical_name":"Aardvark Therapeutics, Inc.","cik":"0001774857","uei":null,"lei":null,"duns":null,"ticker":"AARD"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":19},"count":19,"timeline":[{"ts":"2026-10-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Aardvark Therapeutics, Inc. — 2026-10-08","url_slug":"/sec/cik-0001774857/8-k/0001193125-26-417935","accession_number":"0001193125-26-417935","importance":35},{"ts":"2026-10-08","kind":"sec.filing","form_type":"3","title":"3 — Aardvark Therapeutics, Inc. — 2026-10-08","url_slug":"/sec/cik-0001774857/3/0001193125-26-418016","accession_number":"0001193125-26-418016","importance":30},{"ts":"2026-10-08","kind":"sec.filing","form_type":"4","title":"4 — Aardvark Therapeutics, Inc. — 2026-10-08","url_slug":"/sec/cik-0001774857/4/0001193125-26-418022","accession_number":"0001193125-26-418022","importance":30},{"ts":"2026-09-11","kind":"sec.form144","reporter":"NELSON SUN","title":"Officer","shares":33911,"usd_value":169894,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001950047-26-009373","importance":40.033978822},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Sun Nelson","title":"See Remarks","shares":62000,"price_per_share":5.1803,"usd_value":321179,"security_title":"Common Stock, par value $0.00001 per share","importance":35.3211786},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — Aardvark Therapeutics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001774857/144/0001950047-26-009373","accession_number":"0001950047-26-009373","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Aardvark Therapeutics, Inc. — 2026-09-11","url_slug":"/sec/cik-0001774857/4/0001193125-26-389564","accession_number":"0001193125-26-389564","importance":30},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"Sun Nelson","title":"See Remarks","shares":14754,"price_per_share":5.0006,"usd_value":73779,"security_title":"Common Stock, par value $0.00001 per share","importance":35.0737788524},{"ts":"2026-09-10","kind":"sec.filing","form_type":"144","title":"144 — Aardvark Therapeutics, Inc. — 2026-09-10","url_slug":"/sec/cik-0001774857/144/0001950047-26-009316","accession_number":"0001950047-26-009316","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — Aardvark Therapeutics, Inc. — 2026-08-21","url_slug":"/sec/cik-0001774857/4/0001193125-26-361481","accession_number":"0001193125-26-361481","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — Aardvark Therapeutics, Inc. — 2026-08-21","url_slug":"/sec/cik-0001774857/4/0001193125-26-361489","accession_number":"0001193125-26-361489","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Aardvark Therapeutics, Inc. — 2026-08-17","url_slug":"/sec/cik-0001774857/8-k/0001193125-26-354053","accession_number":"0001193125-26-354053","importance":35},{"ts":"2026-08-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Aardvark Therapeutics, Inc. — 2026-08-11","url_slug":"/sec/cik-0001774857/10-q/0001193125-26-344987","accession_number":"0001193125-26-344987","importance":45},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Aardvark Therapeutics, Inc. — 2026-08-11","url_slug":"/sec/cik-0001774857/8-k/0001193125-26-344978","accession_number":"0001193125-26-344978","importance":35},{"ts":"2026-07-10","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Aardvark Therapeutics, Inc. — 2026-07-10","url_slug":"/sec/cik-0001774857/def-14a/0001193125-26-300874","accession_number":"0001193125-26-300874","importance":40},{"ts":"2026-07-10","kind":"sec.filing","form_type":"ARS","title":"ARS — Aardvark Therapeutics, Inc. — 2026-07-10","url_slug":"/sec/cik-0001774857/ars/0001193125-26-300897","accession_number":"0001193125-26-300897","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Aardvark Therapeutics, Inc. — 2026-06-29","url_slug":"/sec/cik-0001774857/pre-14a/0001193125-26-288409","accession_number":"0001193125-26-288409","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Aardvark Therapeutics, Inc. — 2026-06-12","url_slug":"/sec/cik-0001774857/8-k/0001193125-26-269377","accession_number":"0001193125-26-269377","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Aardvark Therapeutics, Inc. — 2026-05-14","url_slug":"/sec/cik-0001774857/8-k/0001193125-26-224069","accession_number":"0001193125-26-224069","importance":35}]}